Cite

HARVARD Citation

    Becker, E. et al. (2022). Residual homing of α4β7-expressing β1+PI16+ regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab. Gut. 71 (8), pp. 1551-1566. [Online]. 
  
Back to record